Physician profile
Halyna Ivashchuk
NPI 1912361585
$8,631.71
in general payments reported to CMS, 2019-2025
18 companies · $7,981 in 2025
The $7,981 reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $457 · 2023: $51.47 · 2024: $142 · 2025: $7,981.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,000 · Food and Beverage: $1,174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,000.00 |
| Food and Beverage | $1,174.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,000.00 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $377.38 | 2022-2025 | Tezspire |
| Glaxosmithkline, LLC. | $232.33 | 2022-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Actelion Pharmaceuticals US, INC. | $178.74 | 2022-2025 | Uptravi, Opsumit, Opsynvi |
| Regeneron Healthcare Solutions, INC. | $176.26 | 2022-2025 | Dupixent |
| Jazz Pharmaceuticals INC. | $109.87 | 2024-2025 | |
| Insmed, INC. | $91.48 | 2025 | Arikayce, Brinsupri |
| Verona Pharma, INC. | $87.51 | 2025 | Ohtuvayre |
| Philips North America LLC | $63.19 | 2024-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Mylan Specialty L.P. | $55.37 | 2024 | Yupelri |
| Viatris Specialty LLC | $55.03 | 2025 | Yupelri |
| Inspire Medical Systems, INC. | $52.25 | 2025 | Inspire |
| Merck Sharp & Dohme LLC | $36.59 | 2025 | Zerbaxa |
| Electromed, INC. | $36.29 | 2025 | Smartvest |
| Inogen, INC. | $26.38 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Respicardia, INC. | $21.99 | 2025 | Remede System |
| Abbvie INC. | $16.31 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.74 | 2025 | Jascayd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Halyna Ivashchuk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.